Depuis le 1er septembre 2019, le Laboratoire Aguettant doit, comme toutes les entreprises de plus de 250 salariés, publier une...
Our vocation has not changed since the creation of the Aguettant Group. We want to provide every patient with the treatment they need under optimal safety conditions.
We innovate to develop safe medical practices and to make the everyday lives of healthcare professionals easier with the therapeutic solutions of the future.
We are an integrated pharmaceutical company, that performs every step, from research and development to sales.
Our independence enables us to set ourselves international ambitions.
taking action for the world
We help to improve the quality of life of patients suffering from Parkinson’s disease, for whom no treatments are available to stop the disease from developing.
Meeting the population’s priority healthcare needs
medical practices safer
Ready-to-administer medical devices to prevent medication errors
Global command of activities, from the development to the sale of medicines
Ready-to-administer: a key area of research
Guaranteeing efficacy and safety for patients
Know-how that stretches back to 1903
Symptomatic treatment of Parkinson’s disease
Our medicines are used in anaesthesia and intensive care
En s'inscrivant à l'opération collective "Pack e-Engagé RSE" développée par l'AFNOR, le Laboratoire Aguettant s'engage dans une...